Immune landscape of pancreatic cancer development and drug
resistance explores the advances in immune-based therapies aimed at
harnessing the power of the immune system against pancreatic cancer
and rewiring tumor microenvironments to eradicate pancreatic cells.
With a strong focus on the development of therapeutic methods to
improve the survival rates of pancreatic cancer, this book also
shows the latest trends in immune targeted approaches for
pancreatic cancer treatment. In 12 chapters Immune landscape of
pancreatic cancer development and drug resistance discusses the
current understanding of PC development and its various mutational
and immune features and explore some of the new immune-based
therapies aimed at targeting pancreatic cancer. It covers the
urgent need for developing novel therapeutic modalities and aims at
delineating future fields and avenues of research in pancreatic
cancer treatment. The book provides the reader with an updated
understanding of the immune landscape of PC and an all-encompassing
overview of the latest trends in immune targeted approaches for PC
treatment. This book is a valuable resource for health
professionals, scientists and researchers, students, and all those
who wish to broaden their knowledge of the advances in
immunotherapy in pancreatic cancer.
General
Imprint: |
Academic Press Inc
|
Country of origin: |
United States |
Series: |
Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy |
Release date: |
March 2024 |
First published: |
2024 |
Editors: |
Batoul Farran
• Ganji Purnachandra Nagaraju
|
Pages: |
330 |
ISBN-13: |
978-0-443-23523-8 |
Categories: |
Books
Promotions
|
LSN: |
0-443-23523-6 |
Barcode: |
9780443235238 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!